Optimizing Perioperative Therapy in Triple-Negative Breast Cancer

(MedPage Today) -- The treatment landscape for early-stage triple-negative breast cancer (TNBC) continues to evolve with evidence from ongoing neoadjuvant and adjuvant therapy trials.
A major development was the KEYNOTE-522 trial that established...